Alexandra Kropotova
Vermogen: 155 275 $ op 31-08-2026
Vermogen: 155 275 $ op 31-08-2026
Dr. Alexandra Kropotova is a Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. and an Independent Director at iBio, Inc. She is on the Board of Directors at iBio, Inc. Dr. Kropotova was previously employed as a VP-Global Specialty Research & Development by Teva Pharmaceuticals, Inc., a Vice President-Strategy & Head-Strategic Planning by Sanofi, and a Director & Head-Global Clinical Respiratory by Pfizer Inc. She received her MBA from Ohio University Graduate College and a doctorate degree from Pacific State Medical University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-09-2026 | 41.853 ( 0,05% ) | 155 275 $ | 31-08-2026 | |
IBIO, INC. -.--% | 01-09-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IBIO, INC. | Directeur/Bestuurslid | 14-10-2020 |
| SAB BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 06-06-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01-06-2022 |
| SANOFI | Corporate Officer/Principal | 01-01-2016 |
| PFIZER INC. | Directeur/Bestuurslid | 01-01-2007 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Ohio University Graduate College
Ohio University Graduate College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau